Skip to main content

$0.099 (0.00%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
5 June 2026 at 5:21pm
Register to track LV1 and receive email alerts.

Successful FDA Registration and Commencement of US Sales

StockBot

416,823 posts

LV1 released this announcement to the ASX on 22 April 2021, 9:15. The announcement is marked as price sensitive, and is 3 page(s) in length and 139.12kb in size.

You can view all announcements from LV1 and see how they appear on a price chart on the announcements page.

At the date of this announcement, LV1 was 0.000% short sold according to ASIC data. It was ranked the 667th most shorted stock on the ASX. It is now ranked as the 614th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (09 January 2025).

Other Recent Announcements from LV1
LV1 March 2023 Quarterly Business Review & Appendix 4C 28 April 2023, 17:59
Results of General Meeting 24 April 2023, 13:26
Notice of General Meeting/Proxy Form 24 March 2023, 15:46
Successful FDA Registration and Commencement of US Sales 22 April 2021, 9:15
Appendix 3G 9 April 2021, 18:02
LV1 Commences Distribution on Amazon Australia Marketplace 6 April 2021, 9:38
Ex Swiss Wellness Product Development manager appointed CTO 23 March 2021, 9:56
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track LV1 and receive email alerts.